ViralClear Publishes in F1000 Research In Vitro Data Demonstrating Synergy between Merimepodib and Remdesivir Against SARS-CoV-2, the Cause of COVID-19

Press/Media: Expert Comment

PeriodMay 14 2020

Media coverage

16

Media coverage